Swedbank AB Invests $1.09 Million in Afya Limited $AFYA

Swedbank AB bought a new stake in shares of Afya Limited (NASDAQ:AFYA) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 70,000 shares of the company’s stock, valued at approximately $1,092,000. Swedbank AB owned about 0.07% of Afya as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently bought and sold shares of AFYA. Goldman Sachs Group Inc. grew its holdings in Afya by 167.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 45,093 shares of the company’s stock valued at $809,000 after purchasing an additional 28,226 shares during the last quarter. Doma Perpetual Capital Management LLC boosted its position in shares of Afya by 4.4% during the first quarter. Doma Perpetual Capital Management LLC now owns 592,220 shares of the company’s stock valued at $10,619,000 after buying an additional 25,111 shares during the period. Dynamic Technology Lab Private Ltd purchased a new position in shares of Afya during the second quarter valued at approximately $391,000. Carrera Capital Advisors purchased a new stake in shares of Afya in the second quarter worth approximately $1,750,000. Finally, Campbell & CO Investment Adviser LLC lifted its stake in shares of Afya by 31.5% during the 2nd quarter. Campbell & CO Investment Adviser LLC now owns 51,340 shares of the company’s stock worth $917,000 after acquiring an additional 12,286 shares during the last quarter. 88.02% of the stock is currently owned by institutional investors.

Afya Price Performance

Shares of NASDAQ:AFYA opened at $14.95 on Friday. Afya Limited has a twelve month low of $13.47 and a twelve month high of $19.90. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 0.21. The company has a market cap of $1.40 billion, a PE ratio of 10.76, a price-to-earnings-growth ratio of 0.53 and a beta of 0.52. The company’s 50 day moving average is $14.65 and its 200 day moving average is $15.33.

Analyst Ratings Changes

A number of research firms have weighed in on AFYA. JPMorgan Chase & Co. upgraded Afya from a “neutral” rating to an “overweight” rating and increased their target price for the stock from $23.50 to $24.50 in a research note on Monday, September 8th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Afya in a research note on Wednesday, October 8th. Wall Street Zen cut shares of Afya from a “strong-buy” rating to a “buy” rating in a research report on Saturday, December 20th. Finally, UBS Group upgraded shares of Afya from a “neutral” rating to a “buy” rating and dropped their target price for the stock from $19.50 to $19.00 in a research note on Monday, September 8th. Three research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $18.75.

Afya Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.